KRYS - Krystal Biotech, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5808.86M
Enterprise Value 3580.53M
Trailing P/E N/A
Forward P/E 1-21.37
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.82
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-33.42

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3163.33%
S&P500 52-Week Change 30.90%
52 Week High 351.67
52 Week Low 314.30
50-Day Moving Average 345.66
200-Day Moving Average 333.10

Share Statistics

Avg Vol (3 month) 3226.78k
Avg Vol (10 day) 3115.98k
Shares Outstanding 514.44M
Float 9.01M
% Held by Insiders 132.99%
% Held by Institutions 143.14%
Shares Short (Jul 31, 2019) 41.01M
Short Ratio (Jul 31, 2019) 44.95
Short % of Float (Jul 31, 2019) 410.66%
Short % of Shares Outstanding (Jul 31, 2019) 45.84%
Shares Short (prior month Jun 28, 2019) 4624.34k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-8.84%
Return on Equity (ttm)-13.07%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -17.37M
Net Income Avi to Common (ttm)-15.92M
Diluted EPS (ttm)-1.20
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)195.47M
Total Cash Per Share (mrq)11.3
Total Debt (mrq)3.36M
Total Debt/Equity (mrq)1.70
Current Ratio (mrq)49.80
Book Value Per Share (mrq)11.70

Cash Flow Statement

Operating Cash Flow (ttm)-12.88M
Levered Free Cash Flow (ttm)-12.17M